Report DMCA Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34 + CXCR4 + cells in patients wi
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.